newsfilter
← Latest News
GlobeNewswire·

Amryt Announces Successful Bioavailability Study for Mycapssa® (octreotide capsules)

Amryt Announces Successful Bioavailability Study for Mycapssa® (octreotide capsules) Data supports a planned Phase 3 study in the treatment of carcinoid symptoms associated with Neuroendocrine Tumors (NET) Global NET market opportunity is estimate